News

Novo Nordisk (NVO) Extends Fall on 3rd Day as Pessimistic Outlook Lingers
We recently published 10 Stocks Hit by Painful Plunge. Novo Nordisk A/S (NYSE:NVO) is one of the best-performing stocks on ...
Wegovy maker Novo's profit warning triggers $70 billion share rout
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
C-suite shuffles ripple through pharma
In May, the Danish pharma said CEO Lars Fruergaard Jørgensen would step down, following a turn in the obesity market. While Novo was the star of the emerging weight loss and diabetes market through ...
Devdiscourse1d
Pharma Industry Shaken: New Leadership and Tariff Challenges
Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...
Novo's new CEO faces sceptical investors with Wegovy US sales in focus
Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...
Instant View: Reaction to new Novo Nordisk CEO, profit warning
Novo's problems are much deeper than just compunded Wegovy in the U.S. and extend to the international Wegovy franchise and ...